Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Nov 1, 2013 | Envisia Therapeutics | $25.0M Series A | — | Canaan Partners, Canaan Partners, Morningside, New Enterprise Associates, Pappas Ventures |
| Jun 24, 2008 | rPath | $10.0M Series C | General Catalyst, North Bridge Venture Partners, Wakefield Group | — |